Arrhythmia detection by Extended ambulatory continuous electrocardiography patch monitoring system in a tertiary care hospital in India
Background: Ambulatory electrocardiography is routinely used to detect paroxysmal arrhythmias. Although 24-hour Holter monitoring is commonly used, its diagnostic yield for infrequent arrhythmias is limited. WebCardio is a patch-based ambulatory monitoring device that can record for 3 days or up to 7 days and may improve arrhythmia detection. Objective: To evaluate the utility of Web Cardio, a patch-based device that uses two-channel ECG monitoring with cloud-based storage of recorded rhythms for 3 days or 7 days, in patients with symptoms suggestive of paroxysmal arrhythmias. Methods: The Web Cardio patch device was attached to patients with suspected paroxysmal arrhythmias in the Department of Cardiology, PSGIMSR, for 3 days (3-day cohort) or for up to 7 days (7-day cohort), and the recordings were evaluated. The two cohorts were analyzed separately and were not pooled. The ability to detect any of the following arrhythmias was analyzed: atrial fibrillation (AF), atrioventricular (AV) block, sinus pause of more than 2.5 seconds, supraventricular tachycardia (SVT), ventricular tachycardia (VT). Results: In the 3-day cohort, 1076 patients with symptoms suggestive of paroxysmal arrhythmias underwent Web Cardio patch monitoring (mean age 55.86 ± 19.60 years; 639 [59.39%] male and 437 [40.61%] female). A total of 1076 patients were monitored, the most frequent being supraventricular tachycardia (SVT; 472), ventricular tachycardia (VT; 191), second-degree AV block (109), pauses (100), atrial fibrillation (AF; 89), complete heart block (CHB; 37), and >2:1 AV block (4). A substantial proportion of events were first detected after the initial 24 hours: 30.95% of AF, 35.17% of SVT, 40.84% of pauses, and 44.0% of VT. In the separate 7-day cohort (n = 29; mean age 66.41 ± 14.71 years; 16 male [55.17%] and 13 females [44.83%]), at least one arrhythmia was detected in 25 patients (86.21%): SVT in 19 (65.52%), AV block in 9 (31.03%), pauses in 9 (31.03%), VT in 4 (13.79%), and AF in 1 (3.45%). Findings with potential management relevance, including conduction disease, pauses, VT, and AF, were identified in both cohorts and are relevant to decisions on pacing, anticoagulation, and further electrophysiological evaluation. Conclusion: Prolonged, continuous patch-based ECG monitoring with the Web Cardio system demonstrated clinical utility by detecting a substantial burden of clinically actionable arrhythmias, including significant conduction abnormalities, pauses, ventricular arrhythmias, and atrial fibrillation. In the 3-day cohort (n = 1,076), a considerable proportion of AF, SVT, pauses, and VT events were first detected after 24 hours, suggesting that shorter recordings may under-detect clinically relevant arrhythmias. In the separate 7-day cohort (n = 29), at least one arrhythmia was detected in 25 patients (86.21%), most commonly SVT (65.52%), followed by AV block and pauses (31.03% each) and VT (13.79%). The cohorts were analyzed separately and were not pooled. The detection of conduction disease, pauses, VT, and AF provides clinically meaningful information with potential implications for pacing evaluation, anticoagulation, antiarrhythmic therapy, and electrophysiological referral. Although downstream management decisions and patient outcomes were not assessed, these findings support the diagnostic and potential clinical utility of extended WebCardio patch monitoring in patients with suspected paroxysmal arrhythmias.